IBCM Pharma SRL
IBCM Pharma reported total assets of 100,830 € at the end of the 2025 financial year (annual accounts filed with the NBB on 29 Jun 2026).
The score of IBCM Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +417 % Total assets +289 %
Accounts of the company itself (not consolidated).
The full file covers 4 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
IBCM Pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 29 Jun 2026
- Year ended 31 Dec 2024filed on 14 Jul 2025
- Year ended 31 Dec 2023filed on 24 Jul 2024
- Year ended 31 Dec 2022filed on 24 Jul 2023
IBCM Pharma's financial analysis
- Solvency78.5%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of IBCM Pharma
IBCM Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0782.323.509
- VAT number
- BE0782323509
- Peppol
- Registered · 0208:0782323509 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 17 Feb 2022
- Registered office
- 1380 Lasne
- Latest accounts
- 2025 · filed on 29 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
IBCM Pharma (SRL) has been based in Lasne since 2022, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 21,109 € and equity of 79,108 €; its revenue is not published. Its solvency stands at 78.5%, above the median of its sector (41.5%).
Companies similar to IBCM Pharma
Companies in the same business, of comparable size and area, outside its group.
- Novafontis Business and other management consultancy activities Liège · balance sheet 131,719 €
- CosProf Studio Business and other management consultancy activities Niel · balance sheet 120,568 €
- BERA Business and other management consultancy activities Antwerp · balance sheet 140,519 €
- Galeni K. Business and other management consultancy activities Zutendaal · balance sheet 67,285 €
- Lintström Business and other management consultancy activities Schilde · balance sheet 64,321 €
- Swilem Pharmaceuticals Business and other management consultancy activities Evere · balance sheet 292,979 €
- Neopharm Retail sale of pharmaceutical products Jette · balance sheet 94,350 €
- Sander Koyen Retail sale of pharmaceutical products Wuustwezel · balance sheet 82,286 €
Frequently asked questions about IBCM Pharma
What is the revenue of IBCM Pharma?
IBCM Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of IBCM Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0782323509 for IBCM Pharma, if the company is VAT-registered. Its company number (CBE) is 0782.323.509.
Where is the registered office of IBCM Pharma?
According to the CBE register, the registered office of IBCM Pharma is in 1380 Lasne.
What is the equity of IBCM Pharma?
At the close of the 2025 financial year, the equity of IBCM Pharma amounts to 79,108 €, a solvency of 78.5% of total assets.
Who manages IBCM Pharma?
The register lists 1 active mandates at IBCM Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of IBCM Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →